| Heading: |
Puberty Suppressing Hormones: Clinical Trials |
| Question ID: |
1782599 |
| UIN: |
HL5589 |
| House: |
Lords |
| Date tabled: |
2025-03-10 |
| Asking Member ID: |
3756 |
| Asking Member display name: |
Baroness Deech
|
| Asking Member handle: |
BaronessDeech
|
| Asking Member Twitter reference: |
@BaronessDeech
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government what assessment they have made of the safety of the puberty blocker clinical trial to be undertaken by the NHS this year; and whether the trial is compatible with the indefinite ban on puberty blockers for under-18s announc |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-03-27 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Cass Review, which was the most robust evaluation of gender healthcare in the United Kingdom to date, took stock of all the available evidence regarding use of puberty blockers and concluded that, at present, there is insufficient evidence to support ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |